Related references
Note: Only part of the references are listed.Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual
Peter J. Halfmann et al.
VIRUS EVOLUTION (2023)
Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID-19 convalescent plasma therapy
David Gachoud et al.
BRITISH JOURNAL OF HAEMATOLOGY (2023)
Prolonged COVID-19 Infection in a Patient with Newly Diagnosed HIV/AIDS
Tom Ketels et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2022)
Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency
Julia Lang-Meli et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2022)
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis
Thomas Hueso et al.
LEUKEMIA (2022)
Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency - Three consecutive cases and review of the literature
Marcial Delgado-Fernandez et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2022)
Vax-Plasma in Patients With Refractory COVID-19
Eloy E. Ordaya et al.
MAYO CLINIC PROCEEDINGS (2022)
Efficacy of Convalescent Plasma to Treat Mild to Moderate COVID-19 in Kidney Transplant Patients: A Propensity Score Matching Analysis
Marina Pontello Cristelli et al.
TRANSPLANTATION (2022)
COVID-19 in Recent Lung Transplant Recipients: Clinical Outcomes and Management Strategies
Julia Zimmermann et al.
TRANSPLANTATION PROCEEDINGS (2022)
Prolonged COVID-19 infection in a child with lymphoblastic non-Hodgkin lymphoma: which is the best management?
Giovanna Gattuso et al.
TUMORI JOURNAL (2022)
Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies
Aude Jary et al.
VIRUSES-BASEL (2022)
Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases
Oskar Ljungquist et al.
INFECTIOUS DISEASES (2022)
Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient
Carly M. Hughes et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)
Pharmacokinetics of high-titer anti- SARS-CoV-2 human convalescent plasma in high-risk children
Oren Gordon et al.
JCI INSIGHT (2022)
Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics
Afrah S. Sait et al.
TRANSPLANTATION DIRECT (2022)
Acute Cerebellitis and Myeloradiculitis Associated With SARS-CoV-2 Infection in Common Variable Immunodeficiency-A Case Report
Hernan Nicolas Lemus et al.
NEUROHOSPITALIST (2022)
Heart Transplantation Complicated by COVID-19 Infection
Thomas Martens et al.
ANNALS OF THORACIC SURGERY (2022)
Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell-Depleted Patients
Arvind Gharbharan et al.
CLINICAL INFECTIOUS DISEASES (2022)
Specific T-cell responses for guiding treatment with convalescent plasma in severe COVID-19 and humoral immunodeficiency: a case report
Katarina Nystrom et al.
BMC INFECTIOUS DISEASES (2022)
Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations
Daniele Focosi et al.
EXPERT REVIEW OF VACCINES (2022)
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi et al.
CLINICAL MICROBIOLOGY REVIEWS (2022)
Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series
Susanne Rufenacht et al.
INFECTION (2022)
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)
Simone Cesaro et al.
LEUKEMIA (2022)
SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity
Sophie Steiner et al.
FRONTIERS IN IMMUNOLOGY (2022)
Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases
Carlos Martinez-Chinchilla et al.
FRONTIERS IN IMMUNOLOGY (2022)
Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report
Martina Di Palma et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2022)
Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer A Systematic Review and Meta-analysis
Emma Khoury et al.
JAMA NETWORK OPEN (2022)
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern
Maggie Li et al.
BLOOD ADVANCES (2022)
COVID-19-Associated Pneumonia in a B-Cell-Depleted Patient With Non-Hodgkin Lymphoma: Recovery With Hyperimmune Plasma
Daniele Colombo et al.
JOURNAL OF HEMATOLOGY (2022)
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
Ferenc Magyari et al.
ANNALS OF HEMATOLOGY (2022)
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma
Lise J. Estcourt et al.
ANNALS OF INTERNAL MEDICINE (2022)
Monoclonal antibody therapies against SARS-CoV-2
Daniele Focosi et al.
LANCET INFECTIOUS DISEASES (2022)
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients
Massimo Franchini et al.
VIRUSES-BASEL (2022)
SARS-CoV-2 evolution in a patient with secondary B-cell immunodeficiency: A clinical case
Olgo A. Mukhina et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)
Clinical and Virological Response to Convalescent Plasma in a Chronic Lymphocytic Leukemia Patient with COVID-19 Pneumonia
Giovanni Belcari et al.
LIFE-BASEL (2022)
Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment Pathway
Alessandra D'Abramo et al.
FRONTIERS IN IMMUNOLOGY (2022)
Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma
Zachary Wright et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019
Martin Martinot et al.
CLINICAL INFECTIOUS DISEASES (2021)
What is the optimal usage of coronavirus disease 2019 convalescent plasma donations? Comment
Daniele Focosi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study
Isabelle Meyts et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient
Ji Hoon Baang et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report
Michelle C. Nguyen et al.
TRANSPLANTATION DIRECT (2021)
Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia
Ravi Shankar et al.
TRANSFUSION AND APHERESIS SCIENCE (2021)
High-titre convalescent plasma therapy for an immunocompromised patient with systemic lupus erythematosus with protracted SARS-CoV-2 infection
Sara Moutinho-Pereira et al.
BMJ CASE REPORTS (2021)
Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City
Hsi-en Ho et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada
David N. Fisman et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)
Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies
Silvia Ferrari et al.
LEUKEMIA & LYMPHOMA (2021)
COVID-19 in Solid Organ Transplant Recipients: Observations From Connecticut
Heather L. Kutzler et al.
TRANSPLANTATION (2021)
Successful Treatment of Persistent SARS-CoV-2 Infection in a B-Cell Depleted Patient with Activated Cytotoxic T and NK Cells: A Case Report
Jacek Jassem et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency
Nicolai S. C. van Oers et al.
CLINICAL IMMUNOLOGY (2021)
Prolonged viral positivity induced recurrent coronavirus disease 2019 (COVID-19) pneumonia in patients receiving anti-CD20 monoclonal antibody treatment Case reports
Burak Deveci et al.
MEDICINE (2021)
Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: Balancing immunosuppression
Matthias Lubnow et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma
Aled Iaboni et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2021)
Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia
Emily McKemey et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2021)
Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
Philipp A. Reuken et al.
LEUKEMIA (2021)
SARS-CoV-2 evolution during treatment of chronic infection
Steven A. Kemp et al.
NATURE (2021)
Two patients with rituximab associated low gammaglobulin levels and relapsed covid-19 infections treated with convalescent plasma
Irati Ormazabal Velez et al.
TRANSFUSION AND APHERESIS SCIENCE (2021)
Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies
Preethi Jeyaraman et al.
TRANSFUSION AND APHERESIS SCIENCE (2021)
Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19
Monika Maria Biernat et al.
VIRUSES-BASEL (2021)
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
Arturo Casadevall et al.
MBIO (2021)
Rapid clinical recovery of a SARS-CoV-2 infected common variable immunodeficiency patient following the infusion of COVID-19 convalescent plasma
Luciana C. Ribeiro et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2021)
Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
Yusri Taha et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2021)
COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?
D. Rnjak et al.
TRANSFUSION CLINIQUE ET BIOLOGIQUE (2021)
Successful Management of COVID-19 Infection in 2 Early Post-Liver Transplant Recipients
Miles Dale et al.
TRANSPLANTATION PROCEEDINGS (2021)
COVID-19 Infection Clinical Profile, Management, Outcome, and Antibody Response in Kidney Transplant Recipients: A Single Centre Experience
Sanjiv Jasuja et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2021)
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure
Verena Keitel et al.
FRONTIERS IN IMMUNOLOGY (2021)
Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery
Aurelia Zimmerli et al.
FRONTIERS IN IMMUNOLOGY (2021)
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series
Thao T. Truong et al.
EBIOMEDICINE (2021)
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study
Chiara Sepulcri et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
The Three Pillars of COVID-19 Convalescent Plasma Therapy
Massimo Franchini et al.
LIFE-BASEL (2021)
Bamlanivimab plus etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies
F. Pommeret et al.
ANNALS OF ONCOLOGY (2021)
Undetectable SARS-CoV-2 active adaptive immunity-post-vaccination or post-COVID-19 severe disease-after immunosuppressants use
Oluwafeyi Adedoyin et al.
BMJ CASE REPORTS (2021)
Complicated and persistent severe COVID-19 pneumonia in a recipient of allogeneic haematopoietic stem cell transplant
Lorenzo Lazzari et al.
BMJ CASE REPORTS (2021)
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience
Maria Grazia Cusi et al.
BMC INFECTIOUS DISEASES (2021)
Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products
Ariel Kenig et al.
CLINICAL IMMUNOLOGY (2021)
Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy
Anna Furlan et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Clearance of the SARS-CoV-2 Virus in an Immunocompromised Patient Mediated by Convalescent Plasma without B-Cell Recovery
Maamoun Basheer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature
Akshay Khatri et al.
JOURNAL DE MYCOLOGIE MEDICALE (2021)
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
Aziz Sheikh et al.
LANCET (2021)
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome
Ilana Levy et al.
LEUKEMIA & LYMPHOMA (2021)
COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review
Alicia Rodriguez-Pla et al.
RHEUMATOLOGY INTERNATIONAL (2021)
Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19-A case series
Johanna Erber et al.
TRANSFUSION AND APHERESIS SCIENCE (2021)
Convalescent plasma treatment for early post-kidney transplant acquired COVID-19
Malte A. Kluger et al.
TRANSPLANT INFECTIOUS DISEASE (2021)
Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy
Berislav Bosnjak et al.
FRONTIERS IN IMMUNOLOGY (2021)
Case Report: Remdesivir and Convalescent Plasma in a Newly Acute B Lymphoblastic Leukemia Diagnosis With Concomitant Sars-CoV-2 Infection
Giovanni Battista Dell'Isola et al.
FRONTIERS IN PEDIATRICS (2021)
Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment
Liang Chen et al.
MSPHERE (2021)
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
Michael A. Thompson et al.
JAMA ONCOLOGY (2021)
Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution
Ida Monrad et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews
Massimo Franchini et al.
DIAGNOSTICS (2021)
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia
Katharine J. Bar et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Convalescent Plasma in a Patient with Protracted COVID-19 and Secondary Hypogammaglobulinemia Due to Chronic Lymphocytic Leukemia: Buying Time to Develop Immunity?
Jaap L. J. Hanssen et al.
INFECTIOUS DISEASE REPORTS (2021)
Recovery From COVID-19 Pneumonia in a Heart Transplant Recipient A Case Report
A. Bakhsh et al.
INFECTIOUS DISEASES IN CLINICAL PRACTICE (2021)
Cardiac transplant recipient with COVID-19 induced acute hypoxic respiratory failure: a case report
Ariyon Schreiber et al.
EUROPEAN HEART JOURNAL-CASE REPORTS (2021)
Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium
Sapna A. Mehta et al.
TRANSPLANTATION (2021)
A Case of COVID-19 Re-Infection in a Liver Transplant Patient
Michael Mohseni et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation
Dmitry Balashov et al.
TRANSFUSION AND APHERESIS SCIENCE (2021)
COVID-19 Coinfection with Mycobacterium abscessus in a Patient with Multiple Myeloma
Jose A. Rodriguez et al.
CASE REPORTS IN INFECTIOUS DISEASES (2021)
Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency
Kazuhito Honjo et al.
CELL REPORTS MEDICINE (2021)
Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient
Tali-Anne Szwebel et al.
STEM CELL REVIEWS AND REPORTS (2021)
The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
Noah C. Peeri et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2020)
The convalescent sera option for containing COVID-19
Arturo Casadevall et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis
Olgu Erkin Cinar et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Covid-19: WHO declares pandemic because of alarming levels of spread, severity, and inaction
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma
Alex Niu et al.
BONE MARROW TRANSPLANTATION (2020)
Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma
Estefania Mira et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
Bo Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
A minimal common outcome measure set for COVID-19 clinical research
J. C. Marshall et al.
LANCET INFECTIOUS DISEASES (2020)
Response to COVID-19 in persons with haematological cancers
Stefan Hatzl et al.
LEUKEMIA (2020)
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19
Thomas Hueso et al.
BLOOD (2020)
Outcomes of COVID-19 positive kidney transplant recipients: A single-center experience
Goni Katz-Greenberg et al.
CLINICAL NEPHROLOGY (2020)
Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
Ayse Karatas et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia
Guido Lancman et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Coronavirus Disease 2019 Viremia, Serologies, and Clinical Course in a Case Series of Transplant Recipients
Johanna Christensen et al.
TRANSPLANTATION PROCEEDINGS (2020)
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma
Haoli Jin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19
Tim Luetkens et al.
BLOOD ADVANCES (2020)
Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
Victoria A. Avanzato et al.
CELL (2020)
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
Matthew S. Buckland et al.
NATURE COMMUNICATIONS (2020)
Atypical course of COVID-19 in patient with Bruton agammaglobulinemia
Ivana Milosevic et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2020)
A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma
Joanna L. Moore et al.
AMERICAN JOURNAL OF CASE REPORTS (2020)
Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation
Suresh J. Antony et al.
IDCASES (2020)
Successful recovery of COVID-19-associated recurrent diarrhea and gastrointestinal hemorrhage using convalescent plasma
Li-Bo Zhang et al.
MILITARY MEDICAL RESEARCH (2020)
Concurrent Diagnosis of Acute Myeloid Leukemia and COVID-19: A Management Challenge
Abdul Moiz Khan et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery
Ashok Choudhury et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2020)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
GRADE:: what is quality of evidence and why is it important to clinicians?
Gordon H. Guyatt et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)